Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients
SPLE-VAC
Evaluation of an Educational Intervention on Knowledge and Awareness of Infectious Risk in Splenectomized Patients and on Their Satisfaction With Vaccination Management in an Intra-hospital Outpatient Setting.
1 other identifier
observational
100
1 country
2
Brief Summary
The absence or dysfunction of the spleen is associated with a substantially increased risk of invasive infections that may rapidly progress to fulminant sepsis, including overwhelming post-splenectomy infection (OPSI), a medical emergency with high mortality. Although the risk is greatest in the first two years after splenectomy, it persists lifelong. Preventing infections in patients with anatomical or functional asplenia requires an integrated strategy that includes patient education, early recognition of symptoms, behavioral measures, antibiotic prophylaxis when indicated, and vaccination. Post-splenectomy immunization has been shown to reduce OPSI incidence. Regional and international guidelines recommend vaccination against pneumococcus, Haemophilus influenzae type b, meningococcus (B and ACWY), herpes zoster, diphtheria-tetanus-pertussis, measles-mumps-rubella-varicella, and annual influenza. However, adherence to these recommendations is frequently suboptimal, often due to limited awareness among patients and healthcare professionals. This study involves the intra-hospital vaccination team providing structured vaccination consultations to splenectomized patients hospitalized at the Fondazione Policlinico Universitario "A. Gemelli" IRCCS. During ward consultations, patients receive an educational intervention on asplenia-related infectious risks and preventive measures, supported by standardized informational materials. Effectiveness is evaluated using a pre-post questionnaire assessing knowledge and awareness. Patients completing the vaccination pathway at the outpatient clinic also complete a questionnaire assessing their experience with vaccination management in an intra-hospital setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2026
CompletedStudy Start
First participant enrolled
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 13, 2028
February 2, 2026
January 1, 2026
2 years
January 12, 2026
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Infectious Risk Knowledge, Vaccination Attitudes, and Risk Perception Score
Change from baseline to post-intervention in patients' knowledge of infectious risk, attitudes toward vaccination, and perception of infectious risk following an educational and counseling intervention. The outcome is assessed in splenectomized patients identified and/or managed by the intra-hospital outpatient clinic of the Fondazione Policlinico Universitario "A. Gemelli" IRCCS (FPG). Measure Description: Infectious Risk and Vaccination Awareness Questionnaire for Splenectomized Patients (specifically developed and validated questionnaire). The total score ranges from 16 to 80, with higher scores indicating greater knowledge, more favorable attitudes toward vaccination, and higher perceived infectious risk.
24 months
Secondary Outcomes (3)
Patient Experience with Vaccination Prophylaxis Management Score
24 months
Association Between Infectious Risk Knowledge Score and Socio-demographic Characteristics
24 months
Adherence to the Intra-hospital Vaccination Pathway
24 months
Interventions
an educational intervention aimed at informing patients about the condition of asplenia, the associated infectious risks, and the main preventive measures, with particular emphasis on vaccination prophylaxis. To support the intervention, educational materials will be distributed, including an informational brochure and the "Recommended Vaccinations for Asplenic Patients" schedule.
Eligibility Criteria
Patients splenectomized at the Fondazione Policlinico Universitario A. Gemelli IRCCS, identified during consultation activities in the requesting wards and/or managed by the hospital outpatient vaccination clinic for frail patients.
You may qualify if:
- Adult patients (≥18 years old)
- Patients splenectomized at FPG for whom a vaccination consultation is requested during hospitalization
- Patients who provide signed informed consent to participate in the study and for the processing of personal data for research purposes
You may not qualify if:
- Minor patients
- Lack of signed informed consent for participation in the study and for the processing of personal data for research purposes
- Patients splenectomized at other healthcare facilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Lazio, 00168, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, 00168, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
LAURENTI PATRIZIA, PROFESSOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 21, 2026
Study Start
January 13, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
January 13, 2028
Last Updated
February 2, 2026
Record last verified: 2026-01